---
title: 2016 Schedule
layout: page
---

**Note this is the 2016 schedule. You can see the current meeting schedule when available [here](/schedule.html).**    

Invited talks are limited to 30 minutes with 10 minutes for questions. Selected talks will be limited to 12 minutes with 3 minutes for questions.

## Sunday, April 3rd, 2016

* * *

###### Check-In (2:00 – 9:00pm)

###### Dinner (5:30 – 7:00pm)

###### Keynote (7:00 – 8:00pm)

[Galit Lahav](http://lahav.med.harvard.edu/): "Therapy guided by protein dynamics in single cells"

###### Sponsored Mixer (8:30 – 10:30pm)

## Monday, April 4th, 2016

* * *

######  Breakfast (7:00 – 8:30pm)

Registration for lunch with the PIs

###### Cancer genomics and gene regulation (9:00 – 10:40am)

  * [Ben Raphael](http://compbio.cs.brown.edu/): Computational Characterization of Mutational Heterogeneity in Cancer
  * Julia Lima Fleck: "Integrating mutation and gene expression cross-sectional data to infer cancer progression"
  * Jiguang Wang: "Clonal Evolution of Glioblastoma under Therapy"
  * Pau Creixell: "Kinome-wide Decoding of Determinants of Specificity and Network Attacking Mutations Rewiring Cancer Signaling"
  * Kevin Brennan: "DNA methylation subtyping of head and neck squamous cell carcinoma reveals smoking as a determinant of prognosis and embryonic stem cell-like transcriptional identity"

###### Poster Session 1 (10:45 – 12:00pm)

With coffee

###### Lunch (12:15 – 1:30pm)

###### Tumor Systems Biology I: Migration and Metastasis (1:45 – 3:25pm)

  * Invited Speaker: [Shelly Peyton](http://www.peytonlab.org/): "Synthetic Environments to Predict Metastatic Risk and Drug Response"
  * Pilhwa Lee: "Physical mechanisms of cancer in the transition to metastasis"
  * Annelien Zweemer: "Apoptosis-mediated AXL activation: contribution to metastatic cancers?"
  * Julia Sero: "Multiparametric analysis of YAP/TAZ regulation by focal adhesion signaling"
  * Jorge G.T. Zanudo: "Combinatorial interventions lend insight into the inhibition of TGFß-driven epithelial-mesenchymal transition and the existence of hybrid epithelial-mesenchymal phenotypes"

###### Translational Systems Biology (3:45 – 5:25pm)

  * Invited Speaker: [Andrea Bild](http://pharmacy.utah.edu/pharmtox/faculty/bild.htm): "Combating Subclonal Evolution of Resistant Cancer Phenotypes"
  * John Shen: "A network of deeply conserved synthetic-lethal interactions for exploration of precision cancer therapy"
  * Wendy Fantl: "Molecular heterogeneity of ovarian cancer revealed by high-dimensional mass cytometric profiling"
  * Jiyang Yu: "Systems biology and functional genomics identifies HDAC6 as a non-oncogene addiction hub for inflammatory breast cancers"
  * Mohammad Esfahani: "Noninvasive Cancer Classification Using Diverse Genomic Features in Circulating Tumor DNA"

###### Dinner (5:45 – 7:15pm)

###### AECCSB Business Session  (7:15 – 8:15pm)

###### Mixer (8:30 – 10:30pm)

## Tuesday, April 5th, 2016

* * *

###### Breakfast (7:00 – 8:30am)

###### Tumor Systems Biology II: Microenvironment & Immunotherapy (9:00 – 10:40 am)

  * Invited Speaker: [Yvonne Chen](http://yvchen.bol.ucla.edu/): "Engineering Smarter and Stronger T Cells for Cancer Immunotherapy"
  * Molly Carroll: "Decoding the role of macrophages in ovarian cancer metastasis through a novel in vitro model"
  * Kevin Haigis: "In vivo systems analysis of TNF-a responses in the intestinal epithelium"
  * Stacey Finley: "Predictive model of angiogenic factors in breast tumor tissue"
  * Edward Richards: "TAM family RTKs promote the metastatic niche at the tumor-immune interface through suppressing cytokine production in residing immune cell populations"

###### Poster session 2 (10:45am – 12p)

With coffee

###### Lunch (12:15 -1:30 pm)

###### Systems Pharmacology: Drug Resistance & Combinations (1:45p – 3:25 pm)

  * Invited Speaker: Frank Stegmeier: "Systematic Discovery of Cancer Vulnerabilities"
  * Benedict Anchang: "DRUGNEM: an optimized drug combination strategy using single-cell monotherapy perturbation response that accounts for intratumor heterogeneity"
  * Isaac Harris: "Functional profiling of metabolic liabilities in cancer"
  * Laura Heiser: "A systems biology paradigm to identify therapeutically relevant molecular networks in breast cancer"
  * Adam Palmer: "A curative combination therapy lacks synergy but eradicates drug resistance through independent modes of cell killing"

###### NCI Session 1 (3:45 – 5:15pm)

  * Invited Speaker: [Anne-Lise Børresen-Dale](http://ous-research.no/borresen/): "Multilevel molecular analyses in breast cancer: gauging inter- and intra-tumor heterogeneity and elucidating its role in treatment response."
  * Invited Speaker: [Aaron Meyer](http://asmlab.org/): "Looking across resistance mechanisms to identify molecular commonalities and precision therapy approaches"

###### Lobster Dinner (5:30 – 7:00pm)

###### NCI Session 2 (7:15 – 8:45pm)

  * Invited Speaker: [Raghu Kalluri](http://www.raghukalluri.com), University of Texas
  * Invited Speaker: [Trey Ideker](http://healthsciences.ucsd.edu/som/medicine/research/labs/ideker/Pages/default.aspx): "The Cancer Cell Map Initiative"

## Wednesday, April 6th, 2016

* * *

###### Breakfast (7:00 – 8:30 am)

###### Signaling networks in Cancer (9:00 – 10:40 am)

  * Invited Speaker: [Kevin Janes](http://bme.virginia.edu/janes/index.html): "Pharmacologic Versus Genetic Targeting of Signaling Networks"
  * Maximilian Billman: "State-dependent genetic interactions identify switches in signaling networks"
  * Jacob Stewart-Ornstein: "Causes and consequences of p53 signaling dynamics in tissues and tumors"
  * Alexis Barr: "A dynamical framework for the all-or-none G1/S transition"
  * Danica Wiredja: "Integrating phosphoproteomics data for precision medicine: bioinformatics workflows identify cell cycle phosphoprotein dysregulation in KRAS mutated cell lines treated with novel activators of Protein Phosphatase 2A"

###### Keynote  (11:00 – 12:00pm)

[Gordon B. Mills](http://faculty.mdanderson.org/Gordon_Mills/): "Systems Approach to Cancer"
